UnitedHealth Group Inc (NYSE:UNH) – Stock analysts at Jefferies Financial Group boosted their FY2019 earnings per share (EPS) estimates for UnitedHealth Group in a research note issued to investors on Tuesday, October 15th, Zacks Investment Research reports. Jefferies Financial Group analyst D. Windley now anticipates that the healthcare conglomerate will post earnings per share of $14.97 for the year, up from their prior estimate of $14.82. Jefferies Financial Group has a “Hold” rating and a $235.00 price target on the stock. Jefferies Financial Group also issued estimates for UnitedHealth Group’s Q1 2020 earnings at $4.28 EPS, Q2 2020 earnings at $4.09 EPS, Q3 2020 earnings at $4.23 EPS and FY2021 earnings at $18.88 EPS.
A number of other brokerages have also recently issued reports on UNH. Oppenheimer set a $312.00 price objective on UnitedHealth Group and gave the company a “buy” rating in a report on Friday, July 19th. Deutsche Bank initiated coverage on UnitedHealth Group in a report on Thursday, September 12th. They issued a “hold” rating and a $263.00 price target for the company. Royal Bank of Canada set a $311.00 price target on UnitedHealth Group and gave the company a “buy” rating in a report on Friday, July 19th. BMO Capital Markets cut UnitedHealth Group from an “outperform” rating to a “market perform” rating and cut their price target for the company from $292.00 to $249.00 in a report on Monday, September 30th. Finally, Morgan Stanley cut their price target on UnitedHealth Group from $298.00 to $294.00 and set an “overweight” rating for the company in a report on Thursday, September 26th. Five research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company. The stock presently has an average rating of “Buy” and an average price target of $283.84.
Shares of NYSE UNH traded up $0.51 during midday trading on Friday, reaching $256.97. 2,161,274 shares of the company traded hands, compared to its average volume of 4,544,972. The firm has a market cap of $237.20 billion, a PE ratio of 19.95, a PEG ratio of 1.33 and a beta of 0.61. The stock’s 50-day simple moving average is $234.76 and its 200-day simple moving average is $241.05. UnitedHealth Group has a 12 month low of $208.07 and a 12 month high of $287.94. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.67 and a current ratio of 0.70.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $3.88 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $3.75 by $0.13. The company had revenue of $60.35 billion during the quarter, compared to analysts’ expectations of $59.84 billion. UnitedHealth Group had a return on equity of 25.30% and a net margin of 5.57%. The business’s revenue was up 6.7% on a year-over-year basis. During the same period last year, the business earned $3.41 earnings per share.
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be issued a dividend of $1.08 per share. This represents a $4.32 annualized dividend and a yield of 1.68%. UnitedHealth Group’s dividend payout ratio is currently 33.54%.
In other UnitedHealth Group news, CAO Thomas E. Roos sold 1,177 shares of the business’s stock in a transaction dated Thursday, November 7th. The stock was sold at an average price of $255.04, for a total transaction of $300,182.08. Following the completion of the sale, the chief accounting officer now directly owns 21,687 shares of the company’s stock, valued at approximately $5,531,052.48. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Timothy Patrick Flynn acquired 2,000 shares of the company’s stock in a transaction on Wednesday, August 28th. The shares were purchased at an average cost of $227.55 per share, with a total value of $455,100.00. Following the completion of the acquisition, the director now directly owns 5,524 shares in the company, valued at approximately $1,256,986.20. The disclosure for this purchase can be found here. Insiders have sold a total of 33,177 shares of company stock valued at $7,842,582 over the last three months. Company insiders own 0.87% of the company’s stock.
Several institutional investors have recently bought and sold shares of UNH. First Trust Advisors LP grew its position in shares of UnitedHealth Group by 12.0% during the 1st quarter. First Trust Advisors LP now owns 427,291 shares of the healthcare conglomerate’s stock worth $105,652,000 after buying an additional 45,685 shares during the period. Weaver Consulting Group acquired a new position in shares of UnitedHealth Group during the 1st quarter worth about $88,000. Neville Rodie & Shaw Inc. grew its position in shares of UnitedHealth Group by 10.5% during the 2nd quarter. Neville Rodie & Shaw Inc. now owns 37,933 shares of the healthcare conglomerate’s stock worth $9,256,000 after buying an additional 3,596 shares during the period. Cox Capital Mgt LLC grew its position in shares of UnitedHealth Group by 4.4% in the 2nd quarter. Cox Capital Mgt LLC now owns 8,491 shares of the healthcare conglomerate’s stock valued at $2,072,000 after purchasing an additional 360 shares during the period. Finally, Pensionfund DSM Netherlands grew its position in shares of UnitedHealth Group by 8.0% in the 2nd quarter. Pensionfund DSM Netherlands now owns 24,300 shares of the healthcare conglomerate’s stock valued at $5,929,000 after purchasing an additional 1,800 shares during the period. Institutional investors own 85.66% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Further Reading: Diluted Earnings Per Share
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.